Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas

Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas

(2017) M. Dolera et al.   Veterinary and Comparative Oncology

Expression and targeting of transcription factor ATF5 in dog gliomas

(2017) D. York et al.   Veterinary and Comparative Oncology

Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

(2016) Shamik Chakraborty et al.   JOURNAL OF NEURO-ONCOLOGY

Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles

(2015) Alexandros Bouras et al.   JOURNAL OF NEURO-ONCOLOGY

Systematic Review of Brain Tumor Treatment in Dogs

(2015) H. Hu et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Molecular signalling pathways in canine gliomas

(2015) C. E. Boudreau et al.   Veterinary and Comparative Oncology

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles

(2015) Milota Kaluzova et al.   Oncotarget

Advances in Diagnostic and Treatment Modalities for Intracranial Tumors

(2014) P.J. Dickinson   JOURNAL OF VETERINARY INTERNAL MEDICINE

The application of magnetic nanoparticles for the treatment of brain tumors

(2014) Keon Mahmoudi et al.   Frontiers in Chemistry

Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations

(2013) Neil U. Barua et al.   BRAIN PATHOLOGY

Postmortem Evaluation of 435 Cases of Intracranial Neoplasia in Dogs and Relationship of Neoplasm with Breed, Age, and Body Weight

(2013) R.B. Song et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors

(2013) Waldemar Debinski et al.   PLoS One

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting

(2012) Josef Singer et al.   MOLECULAR IMMUNOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Convection-Enhanced Delivery: From Mechanisms to Clinical Drug Delivery for Diseases of the Central Nervous System

(2012) Ryuta SAITO et al.   NEUROLOGIA MEDICO-CHIRURGICA

Canine Model of Convection-Enhanced Delivery of Cetuximab-Conjugated Iron-Oxide Nanoparticles Monitored With Magnetic Resonance Imaging

(2012) Simon Platt et al.   NEUROSURGERY

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy

(2012) Mamta Wankhede et al.   Expert Review of Clinical Pharmacology

Cetuximab in the treatment of patients with colorectal cancer

(2011) Christopher R Garrett et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Glioblastoma multiforme: Molecular characterization and current treatment strategy (Review)

(2011) XIANG ZHANG et al.   Experimental and Therapeutic Medicine

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma

(2010) C. G. Hadjipanayis et al.   CANCER RESEARCH

Canine spontaneous glioma: A translational model system for convection-enhanced delivery

(2010) P. J. Dickinson et al.   NEURO-ONCOLOGY

Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain

(2010) H.-L. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MAGNETIC RESONANCE IMAGING FEATURES OF INTRACRANIAL ASTROCYTOMAS AND OLIGODENDROGLIOMAS IN DOGS

(2010) BENJAMIN D. YOUNG et al.   VETERINARY RADIOLOGY & ULTRASOUND

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

(2009) B. Neyns et al.   ANNALS OF ONCOLOGY

Designer Therapies for Glioblastoma Multiforme

(2009) Sith Sathornsumetee et al.   Annals of the New York Academy of Sciences

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies

(2009) A Diaz Miqueli et al.   BRITISH JOURNAL OF CANCER

Emerging trends of nanomedicine - an overview

(2009) Selvarajan Sandhiya et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Spontaneous canine gliomas: overexpression of EGFR, PDGFRα and IGFBP2 demonstrated by tissue microarray immunophenotyping

(2009) Robert J. Higgins et al.   JOURNAL OF NEURO-ONCOLOGY

Poor drug distribution as a possible explanation for the results of the PRECISE trial

(2009) John H. Sampson et al.   JOURNAL OF NEUROSURGERY

Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells

(2009) Barry Jutten et al.   RADIOTHERAPY AND ONCOLOGY

Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2

(2008) T. Martens et al.   CLINICAL CANCER RESEARCH

Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging

(2008) Peter J. Dickinson et al.   JOURNAL OF NEUROSURGERY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE